Chronic total occlusion percutaneous coronary intervention in Latin America.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
11 2020
Historique:
received: 04 09 2019
revised: 23 12 2019
accepted: 13 01 2020
pubmed: 29 1 2020
medline: 29 6 2021
entrez: 29 1 2020
Statut: ppublish

Résumé

To report clinical, angiographic characteristics, outcomes, and predictors of unsuccessful procedures in patients who underwent chronic total occlusion (CTO) percutaneous coronary interventions (PCI) in Latin America. CTO PCI has been increasingly performed worldwide, but there is a lack of information in this region. An international multicenter registry was developed to collect data on CTO PCI performed in centers in Latin America. Patient, angiographic, procedural and outcome data were evaluated. Predictors of unsuccessful procedures were assessed by multivariable analysis. We have included data related to 1,040 CTO PCIs performed in seven countries in Latin America (Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, and Puerto Rico). The mean age was 64 ± 10 years, and CTO PCI was performed mainly for angina control (81%) or treatment of a large ischemic area (30%). Overall technical success rate was 82.5%, and it was achieved with antegrade wire escalation in 81%, antegrade dissection/re-entry in 8% and with retrograde techniques in 11% of the successful procedures. Multivariable analysis identified moderate/severe calcification, a blunt proximal cap and a previous attempt as independent predictors of unsuccessful procedures. In-hospital major adverse cardiovascular events (MACE) occurred in 3.1% of the cases, death in 1% and cardiac tamponade in 0.9% CONCLUSIONS: CTO PCI in Latin America has been performed mainly for ischemia relief. Procedures were associated with a success rate above 80% and low incidence of MACE. Predictors of unsuccessful procedures were similar to those previously reported in the literature.

Sections du résumé

OBJECTIVES
To report clinical, angiographic characteristics, outcomes, and predictors of unsuccessful procedures in patients who underwent chronic total occlusion (CTO) percutaneous coronary interventions (PCI) in Latin America.
BACKGROUND
CTO PCI has been increasingly performed worldwide, but there is a lack of information in this region.
METHODS
An international multicenter registry was developed to collect data on CTO PCI performed in centers in Latin America. Patient, angiographic, procedural and outcome data were evaluated. Predictors of unsuccessful procedures were assessed by multivariable analysis.
RESULTS
We have included data related to 1,040 CTO PCIs performed in seven countries in Latin America (Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, and Puerto Rico). The mean age was 64 ± 10 years, and CTO PCI was performed mainly for angina control (81%) or treatment of a large ischemic area (30%). Overall technical success rate was 82.5%, and it was achieved with antegrade wire escalation in 81%, antegrade dissection/re-entry in 8% and with retrograde techniques in 11% of the successful procedures. Multivariable analysis identified moderate/severe calcification, a blunt proximal cap and a previous attempt as independent predictors of unsuccessful procedures. In-hospital major adverse cardiovascular events (MACE) occurred in 3.1% of the cases, death in 1% and cardiac tamponade in 0.9% CONCLUSIONS: CTO PCI in Latin America has been performed mainly for ischemia relief. Procedures were associated with a success rate above 80% and low incidence of MACE. Predictors of unsuccessful procedures were similar to those previously reported in the literature.

Identifiants

pubmed: 31990453
doi: 10.1002/ccd.28744
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1046-1055

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Konstantinidis NV, Werner GS, Deftereos S, et al. Temporal trends in chronic total occlusion interventions in Europe: seventeen thousand six hundred twenty-six procedures from the European Registry of Chronic Total Occlusion. Circ Cardiovasc Interv. 2018;11:e006229.
Tajti P, Burke MN, Karmpaliotis D, et al. Update in the percutaneous management of coronary chronic total occlusions. JACC Cardiovasc Interv. 2018;11:615-625.
Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5:367-379.
Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018;39(26):2484-2493.
Obedinskiy AA, Kretov EI, Boukhris M, et al. The IMPACTOR-CTO Trial. JACC Cardiovasc Interv. 2018;11(13):1309-1311.
Jang WJ, Yang JH, Choi SH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv. 2015;8:271-279.
Tomasello SD, Boukhris M, Giubilato S, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36:3189-3198.
Gao L, Wang Y, Liu Y, Cao F, Chen Y. Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2017;89:574-581.
Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion: the DECISION-CTO trial. Circulation. 2019;139:1674-1683.
Henriques JP, Hoebers LP, Ramunddal T, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE Trial. J Am Coll Cardiol. 2016;68:1622-1632.
Mashayekhi K, Nuhrenberg TG, Toma A, et al. A randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion. The REVASC Trial JACC Cardiovasc Interv. 2018;11:1982-1991.
Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371:818-827.
Corbalán R, Nicolau JC, López-Sendon J, et al. Edoxaban versus Warfarin in Latin American patients with atrial fibrillation: the ENGAGE AF-TIMI 48 trial. J Am Coll Cardiol. 2018;72:1466-1475.
Sapontis J, Salisbury AC, Yeh RW, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO Registry (Outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures). JACC Cardiovasc Interv. 2017;10:1523-1534.
Tajti P, Karmpaliotis D, Alaswad K, et al. The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018;11(14):1325-1335.
Maeremans J, Walsh S, Knaapen P, et al. The hybrid algorithm for treating chronic total occlusions in Europe: The RECHARGE Registry. J Am Coll Cardiol. 2016;68:1958-1970.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC Cardiovasc Interv. 2011;4:213-221.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions the PROGRESS CTO (Prospective Global Registry for the study of chronic total occlusion intervention) score. JACC Cardiovasc Interv. 2016;9:1-9.
Alessandrino G, Chevalier B, Lefèvre T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC Cardiovasc Interv. 2015;8:1540-1548.
Galassi AR, Boukhris M, Azzarelli S, Castaing M, Marzà F, Tomasello SD. Percutaneous coronary revascularization for chronic total occlusions: a novel predictive score of technical failure using advanced technologies. JACC Cardiovasc Interv. 2016;9:911-922.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Circulation. 2018;138:e618-e651.
Hosmer DW, Lemeshow S. Assessing the fit of the model. Hosmer DW, Lemeshow S, eds. In: Applied Logistic Regression, 1a ed. New York, EUA: John Wiley & Sons 1989:135-175.
Suzuki Y, Tsuchikane E, Katoh O, et al. Outcomes of percutaneous coronary interventions for chronic total occlusion performed by highly experienced Japanese specialists: the first report from the Japanese CTO-PCI Expert Registry. JACC Cardiovasc Interv. 2017;10:2144-2154.
Ybarra LF, Cantarelli MJC, Lemke VMG, Quadros AS. Percutaneous coronary intervention in chronic total occlusion. Arq Bras Cardiol. 2018;110:476-483.
Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report From the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8:245-253.
Kinnaird T, Gallagher S, Cockburn J, et al. Procedural success and outcomes with increasing use of enabling strategies for chronic total occlusion intervention. Circ Cardiovasc Interv. 2018;11:e006436.
Habara M, Tsuchikane E, Muramatsu T, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheter Cardiovasc Interv. 2016;87:1027-1035.
Karacsonyi J, Karatasakis A, Karmpaliotis D, et al. Effect of previous failure on subsequent procedural outcomes of chronic total occlusion percutaneous coronary intervention (from a Contemporary Multicenter Registry). Am J Cardiol. 2016;117:1267-1271.
Karatasakis A, Danek BA, Karmpaliotis D, et al. Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention. Int J Cardiol. 2016;224:50-56.
Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20,000-patient Euro CTO Registry. The EuroCTO (CASTLE) Score. JACC Cardiovasc Interv. 2019;12:335-342.
Okamura A, Yamane M, Muto M, et al. Complications during retrograde approach for chronic coronary total occlusion: Sub-analysis of Japanese multicenter registry. Catheter Cardiovasc Interv. 2016;88:7-14.
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;40:87-165.
Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69:2212-2241.

Auteurs

Alexandre Quadros (A)

Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.
Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Brazil.

Karlyse C Belli (KC)

Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.

João E T de Paula (JET)

Instituto Cardiovascular de Linhares UNICOR, Linhares, Brazil.

Antonio C B da Silva (ACB)

Hospital São José do Avaí, Itaperuna, Brazil.

Ricardo Santiago (R)

Hospital Pavia Santurce, San Juan, Puerto Rico.

Marcelo H Ribeiro (MH)

SOS Cardio, Florianópolis, Brazil.

Pedro P de Oliveira (PP)

Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.

Pablo Lamelas (P)

Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Aníbal P Abelin (AP)

ICOR, Santa Maria, Brazil.

Cristiano G Bezerra (CG)

Hospital Cardio-Pulmonar, Salvador, Brazil.

Evandro M Filho (EM)

Santa Casa de Misericórdia de Maceio, Maceió, Brazil.

Felipe C Fuchs (FC)

Hospital Mãe de Deus, Porto Alegre, Brazil.

Félix D de Los Santos (FD)

Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Hospital San Ángel, Mexico City, Mexico.

Pedro B de Andrade (PB)

Santa Casa de Marília, Marília, Brazil.

Franklin L H Quesada (FLH)

Clinica Comfamiliar, Pereira, Colombia.

Mario Araya (M)

Hospital San Juan de Dios, Santiago, Chile.

Luis A Perez (LA)

Hospital Clinico Regional Dr Guillermo Grant Benavente, Concepción, Chile.

Leandro A Côrtes (LA)

Instituto Nacional de Cardiologia, Rio de Janeiro, Brazil.

Cleverson N Zukowski (CN)

Rede D'Or - Copa D'Or, Rio de Janeiro, Brazil.

Marco Alcantara (M)

Centro Médico 20 de Noviembre, Mexico City, Mexico.

Antônio J Muniz (AJ)

Santa Casa de Misericórdia Juiz de Fora, Juiz de Fora, Brazil.

Gustavo C Martinelli (GC)

Hospital Santa Izabel Santa Casa Misericórdia de Salvador, Salvador, Brazil.

Marcelo J de Carvalho Cantarelli (MJ)

Hospital Leforte, São Paulo, Brazil.

Fábio S Brito (FS)

Hospital São Camilo, São Paulo, Brazil.

Sandra Baradel (S)

Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Brazil.

Breno de Alencar Araripe Falcão (B)

Hospital de Messejana, Fortaleza, Brazil.

José A Mangione (JA)

Beneficência Portuguesa de São Paulo, São Paulo, Brazil.

César R Medeiros (CR)

Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Brazil.
Hospital Badim, Rio de Janeiro, Brazil.
Hospital Unimed Rio, Rio de Janeiro, Brazil.

Ramiro C Degrazia (RC)

Hospital Unimed RS, Caxias do Sul, Brazil.
Hospital Nossa Senhora de Pompeia, Caxias do Sul, Brazil.
Hospital Circulo Operario Caxiense, Caxias do Sul, Brazil.

José A N Lecaro (JAN)

Hospital de Especialidades Eugenio Espejo, Quito, Ecuador.
Hospital de Los Valles, Quito, Ecuador.

Silvio Gioppato (S)

Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Brazil.
Hospital de Clínicas da UNICAMP, Campinas, Brazil.
Hospital Vera Cruz, Campinas, Brazil.

Luiz F Ybarra (LF)

London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Daniel Weilenmann (D)

Kantosspital St Gallen, St. Gallen, Switzerland.

Carlos A M Gottschall (CAM)

Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.

Viviana Lemke (V)

Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista, Brazil.

Lucio Padilla (L)

Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH